Edward M. Liddy

This profile gathers the share dealings of Edward M. Liddy across 4 companies, led by 3M Co, Allstate Corp and Abbott Laboratories. In total, 102 filings cover trades dated from 13 February 2006 to 7 May 2021.

In open-market terms, that means 1 purchase worth €49k on one side and 2 sales worth €32.0M on the other. Taken together, the sales exceed the purchases by €31.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 92 share grants and 7 option exercises.

Most recently, on 11 May 2021, the filings show a share grant in AbbVie Inc. The latest purchase dates back some time: it was published 3,365 days ago, on 22 August 2017. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.